PBCRY yields 0.51% · JNJ yields 2.14%● Live data
📍 PBCRY pulled ahead of the other in Year 1
Combined, PBCRY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PBCRY + JNJ for your $10,000?
PT Bank Central Asia Tbk, together with its subsidiaries, provides banking products and services to individual, corporate, and small and medium enterprise customers in Indonesia and internationally. It offers savings accounts; motorcycle financing, as well as car, housing, working capital, and investment loans; mutual funds and bonds; electronic money services; credit cards; business collection services; and home and eBanking, remittance, and customer services. The company also provides investment financing, working capital financing, auto and multipurpose financing, operating lease, other financing activities, money lending and remittance, securities brokerage dealing and securities issuance underwriting, general or loss insurance, life insurance, Sharia banking, and venture capital services. As of December 2021, it operated 1,334 offices comprising 137 main branch offices; 1,105 permanent sub-branch offices; 70 mobile sub-branch offices; and 22 functional offices, as well as total 18,034 automated teller machines (ATMs) consisting of cash recycling machines and multi-functional ATMs. PT Bank Central Asia Tbk was founded in 1955 and is headquartered in Jakarta, Indonesia. PT Bank Central Asia Tbk is a subsidiary of PT Dwimuria Investama Andalan.
Full PBCRY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.